Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,217 | 15,719 | 17,043 | 16,588 | 14,645 |
| Receivables | 16,742 | 16,272 | 17,334 | 16,632 | 16,595 |
| Inventories | 16,272 | 14,636 | 14,020 | 14,406 | 15,341 |
| Income taxes - deferred | 2,957 | 556 | 556 | 573 | 334 |
| TOTAL | $53,188 | $47,183 | $48,953 | $48,199 | $46,915 |
| Non-Current Assets | |||||
| PPE Net | 3,255 | 3,249 | 3,349 | 3,545 | 3,236 |
| Intangibles | 56,371 | 51,648 | 52,923 | 54,513 | 18,379 |
| Other Non-Current Assets | 7,530 | 824 | 760 | 974 | 37,944 |
| TOTAL | $67,156 | $55,721 | $57,032 | $59,032 | $59,559 |
| Total Assets | $120,344 | $102,904 | $105,985 | $107,231 | $106,474 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,734 | 4,943 | 4,939 | 4,856 | 4,304 |
| Accrued Expenses | 4,426 | 3,828 | 4,306 | 4,049 | 4,646 |
| Other current liabilities | 235 | 883 | 2,323 | 2,906 | 12,706 |
| TOTAL | $9,807 | $10,181 | $12,147 | $12,258 | $22,168 |
| Non-Current Liabilities | |||||
| Long Term Debt | 18,009 | 11,156 | 11,807 | 13,308 | 9,009 |
| Deferred Revenues | 409 | 524 | 573 | 434 | 483 |
| Other Non-Current Liabilities | 3,961 | 3,895 | 4,060 | 4,371 | 2,167 |
| TOTAL | $22,105 | $17,237 | $17,922 | $19,716 | $12,428 |
| Total Liabilities | $31,912 | $27,418 | $30,069 | $31,974 | $34,596 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28,286 | 28,346 | 29,596 | 29,584 | 29,468 |
| Common Shares | 361 | 361 | 360 | 360 | 358 |
| Retained earnings | -85,625 | -98,354 | -100,236 | -102,457 | -106,249 |
| Other shareholders' equity | -2,345 | -5,789 | -3,622 | -1,502 | -104 |
| TOTAL | $88,432 | $75,486 | $75,916 | $75,257 | $71,878 |
| Total Liabilities And Equity | $120,344 | $102,904 | $105,985 | $107,231 | $106,474 |